NP Inc.

Equities

A291230

KR7291230001

Advertising & Marketing

End-of-day quote Korea S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
2,720 KRW +2.84% Intraday chart for NP Inc. +2.64% -16.31%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ultra Lithium Provides Bi-Weekly Default Status Report MT
Shanaya’s Subsidiary Enters MOU with Ngee Ann Polytechnic; Shares Surge 10% MT
Algernon Pharmaceuticals Says Acquisition of Ifenprodil Program Completed by US Company MT
Down 17%, BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update MT
MCF Energy Acquired "Accretive" Czech Gas Projects With "Immediate Production And Growth Potential" MT
MCF Energy Acquires Accretive Czech Gas Projects with Immediate Production and Growth Potential MT
Vizsla Silver Up 0.75% In US Premarket After Reporting Additional High Grade Intercepts at La Luisa MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD MT
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast MT
Algernon Pharma in LOI For Acquisition of its Chronic Cough Research Program For US$2 Million and 20% Equity Stake MT
Aehr Test Systems Receives Initial Order From Unnamed New Customer for Wafer Level Test, Burn-in Systems MT
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH MT
Novelplus Technology Trims Loss in H1 MT
Napo Pharmaceuticals Submits Funding Application to BARDA for NP-300 Development MT
Moody's Withdraws Ratings on Austria's Addiko Bank MT
Algernon Pharmaceuticals Engage Maxim Group to Explore Spin-Off of Ifenprodil Phase 2 Chronic Cough Drug Development Program MT
Algernon Pharmaceuticals Receives Notice of Allowance From Japanese Patent Office for Repirinast and Treatment of CKD MT
Vizsla Silver Up More Than 6% In US Pre-Market On Extending High Grade Mineralization at La Luisa and Defining New Exploration Targe to the North MT
NP Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Former UN chief Ban returns to Myanmar, meets ruling general RE
Titan Medical Announcing Receipt of MCTO MT
Keppel Philippines Properties Divesting 50% Stake in SM Keppel Land MT
An Unknown buyer agreed to acquire 8.999% stake in NP Inc. from Wysiwyg Studios Co., Ltd. for KRW 30.7 billion. CI
Algernon Pharmaceuticals Announces Plans for a 180 Patient Phase 2b Chronic Cough Study of Ifenprodil MT
BeLive Technology Announces Partnership with NP Inc. to Offer Extended Reality Commerce CI
Chart NP Inc.
More charts
NP Inc, formerly Samsung Special Purpose Acquisition 2 Co Ltd is a Korea-based company mainly engaged in the advertising content planning and production business. The Company operates its business through six segments. The Offline Brand Experience (BE) segment operates offline advertising content planning and production business. The Online BE segment operates online advertising content planning and production business. The Extended Reality (XR) Content segment is engaged in the planning and producing immersive content. The Performance Planning segment is engaged in the planning and production of performances. The Rental Business segment is engaged in studio rental business. The Other segment is engaged in leasing of idle facilities, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A291230 Stock
  4. News NP Inc.
  5. Napo Pharmaceuticals Submits Funding Application to BARDA for NP-300 Development